187 related articles for article (PubMed ID: 31099113)
1. Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Schneider MP; Tornic J; Sýkora R; Abo Youssef N; Mordasini L; Krhut J; Chartier-Kastler E; Davies M; Gajewski J; Schurch B; Bachmann LM; Kessler TM
Neurourol Urodyn; 2019 Aug; 38(6):1482-1491. PubMed ID: 31099113
[TBL] [Abstract][Full Text] [Related]
2. Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2018 Jan; 37(1):67-82. PubMed ID: 28618110
[TBL] [Abstract][Full Text] [Related]
3. Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Tornic J; Sartori AM; Gajewski JB; Cox A; Schneider MP; Youssef NA; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2018 Nov; 37(8):2315-2322. PubMed ID: 29917273
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.
Abo Youssef N; Schneider MP; Mordasini L; Ineichen BV; Bachmann LM; Chartier-Kastler E; Panicker JN; Kessler TM
BJU Int; 2017 Apr; 119(4):515-521. PubMed ID: 28058780
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2019 Feb; 38(2):563-571. PubMed ID: 30653737
[TBL] [Abstract][Full Text] [Related]
6. The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men.
Fisher E; Subramonian K; Omar MI
Cochrane Database Syst Rev; 2014 Jun; (6):CD006744. PubMed ID: 24913721
[TBL] [Abstract][Full Text] [Related]
7. Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.
Schneider MP; Gross T; Bachmann LM; Blok BF; Castro-Diaz D; Del Popolo G; Groen J; Hamid R; Karsenty G; Pannek J; Hoen L'; Kessler TM
Eur Urol; 2015 Nov; 68(5):859-67. PubMed ID: 26194043
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.
Gross T; Schneider MP; Bachmann LM; Blok BF; Groen J; Hoen LA; Castro-Diaz D; Padilla Fernández B; Del Popolo G; Musco S; Hamid R; Ecclestone H; Karsenty G; Phé V; Pannek J; Kessler TM
Eur Urol; 2016 Jun; 69(6):1102-11. PubMed ID: 26831506
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.
Yan H; Zong H; Cui Y; Li N; Zhang Y
J Sex Med; 2014 Jun; 11(6):1539-45. PubMed ID: 24621088
[TBL] [Abstract][Full Text] [Related]
10. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review.
Musco S; Padilla-Fernández B; Del Popolo G; Bonifazi M; Blok BFM; Groen J; 't Hoen L; Pannek J; Bonzon J; Kessler TM; Schneider MP; Gross T; Karsenty G; Phé V; Hamid R; Ecclestone H; Castro-Diaz D
Neurourol Urodyn; 2018 Jun; 37(5):1522-1540. PubMed ID: 29392753
[TBL] [Abstract][Full Text] [Related]
11. α-adrenergic blockers for the treatment of lower-urinary-tract symptoms and dysfunction in women.
Boyd K; Hilas O
Ann Pharmacother; 2014 Jun; 48(6):711-22. PubMed ID: 24615630
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of the neuro-urological patient: a systematic review.
Averbeck MA; Madersbacher H
BJU Int; 2015 Apr; 115 Suppl 6():39-46. PubMed ID: 25891319
[TBL] [Abstract][Full Text] [Related]
13. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Corona G; Salvi M; Vignozzi L; McVary KT; Kaplan SA; Roehrborn CG; Serni S; Mirone V; Carini M; Maggi M
Eur Urol; 2012 May; 61(5):994-1003. PubMed ID: 22405510
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of Antimuscarinics Alone or in Combination with Alpha-Blockers for the Treatment of Ureteral Stent-Related Symptoms: A Systematic Review and Meta-Analysis.
Yan H; Wang Y; Sun R; Cui Y
Urol Int; 2017; 99(1):6-13. PubMed ID: 27760432
[TBL] [Abstract][Full Text] [Related]
15. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
[TBL] [Abstract][Full Text] [Related]
16. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
[TBL] [Abstract][Full Text] [Related]
17. Deep brain stimulation effects on lower urinary tract function: Systematic review and meta-analysis.
Jörg E; Sartori AM; Hofer AS; Baumann CR; Kessler TM
Parkinsonism Relat Disord; 2020 Oct; 79():65-72. PubMed ID: 32889502
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; (5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.
Dahm P; Brasure M; MacDonald R; Olson CM; Nelson VA; Fink HA; Rwabasonga B; Risk MC; Wilt TJ
Eur Urol; 2017 Apr; 71(4):570-581. PubMed ID: 27717522
[TBL] [Abstract][Full Text] [Related]
20. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up.
Ginsberg DA; Boone TB; Cameron AP; Gousse A; Kaufman MR; Keays E; Kennelly MJ; Lemack GE; Rovner ES; Souter LH; Yang CC; Kraus SR
J Urol; 2021 Nov; 206(5):1106-1113. PubMed ID: 34495688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
